Full Text View
Tabular View
No Study Results Posted
Related Studies
An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia
This study is ongoing, but not recruiting participants.
Study NCT01078675   Information provided by AstraZeneca

First Received on February 25, 2010.   Last Updated on March 21, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Familial Hypercholesterolaemia
Additional conditions recognized in this trial
Hypercholesterolemia
Hyperlipoproteinemia Type II
More general conditions related to this trial
Dyslipidemias
Genetic Diseases, Inborn
Hyperlipidemias
Hyperlipoproteinemias
Lipid Metabolism Disorders
Lipid Metabolism, Inborn Errors
Metabolic Diseases
Metabolism, Inborn Errors
Interventions listed in this trial
rosuvastatin calcium
Additional drug interventions recognized in this trial
Calcium, Dietary
Rosuvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Bone Density Conservation Agents
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services